Literature DB >> 28230307

CDKL5 deficiency entails sleep apneas in mice.

Viviana Lo Martire1, Sara Alvente1, Stefano Bastianini1, Chiara Berteotti1, Alessandro Silvani1, Alice Valli1, Rocchina Viggiano1, Elisabetta Ciani1, Giovanna Zoccoli1.   

Abstract

A recently discovered neurodevelopmental disorder caused by the mutation of the cyclin-dependent kinase-like 5 gene (CDKL5) entails complex autistic-like behaviours similar to Rett syndrome, but its impact upon physiological functions remains largely unexplored. Sleep-disordered breathing is common and potentially life-threatening in patients with Rett syndrome; however, evidence is limited in children with CDKL5 disorder, and is lacking altogether in adults. The aim of this study was to test whether the breathing pattern during sleep differs between adult Cdkl5 knockout (Cdkl5-KO) and wild-type (WT) mice. Using whole-body plethysmography, sleep and breathing were recorded non-invasively for 8 h during the light period. Sleep apneas occurred more frequently in Cdkl5-KO than in WT mice. A receiver operating characteristic (ROC) analysis discriminated Cdkl5-KO significantly from WT mice based on sleep apnea occurrence. These data demonstrate that sleep apneas are a core feature of CDKL5 disorder and a respiratory biomarker of CDKL5 deficiency in mice, and suggest that sleep-disordered breathing should be evaluated routinely in CDKL5 patients.
© 2017 European Sleep Research Society.

Entities:  

Keywords:  animal models; genetic disease; post-sigh apneas; respiration

Mesh:

Substances:

Year:  2017        PMID: 28230307     DOI: 10.1111/jsr.12512

Source DB:  PubMed          Journal:  J Sleep Res        ISSN: 0962-1105            Impact factor:   3.981


  13 in total

1.  Expression of a Secretable, Cell-Penetrating CDKL5 Protein Enhances the Efficacy of Gene Therapy for CDKL5 Deficiency Disorder.

Authors:  Giorgio Medici; Marianna Tassinari; Giuseppe Galvani; Stefano Bastianini; Laura Gennaccaro; Manuela Loi; Nicola Mottolese; Sara Alvente; Chiara Berteotti; Giulia Sagona; Leonardo Lupori; Giulia Candini; Helen Rappe Baggett; Giovanna Zoccoli; Maurizio Giustetto; Alysson Muotri; Tommaso Pizzorusso; Hiroyuki Nakai; Stefania Trazzi; Elisabetta Ciani
Journal:  Neurotherapeutics       Date:  2022-09-15       Impact factor: 6.088

2.  International Consensus Recommendations for the Assessment and Management of Individuals With CDKL5 Deficiency Disorder.

Authors:  Sam Amin; Marie Monaghan; Angel Aledo-Serrano; Nadia Bahi-Buisson; Richard F Chin; Angus J Clarke; J Helen Cross; Scott Demarest; Orrin Devinsky; Jenny Downs; Elia M Pestana Knight; Heather Olson; Carol-Anne Partridge; Graham Stuart; Marina Trivisano; Sameer Zuberi; Tim A Benke
Journal:  Front Neurol       Date:  2022-06-20       Impact factor: 4.086

3.  Negative impact of insomnia and daytime sleepiness on quality of life in individuals with the cyclin-dependent kinase-like 5 deficiency disorder.

Authors:  Jenny Downs; Peter Jacoby; Jacinta Saldaris; Helen Leonard; Tim Benke; Eric Marsh; Scott Demarest
Journal:  J Sleep Res       Date:  2022-04-12       Impact factor: 5.296

4.  Neuron-Type Specific Loss of CDKL5 Leads to Alterations in mTOR Signaling and Synaptic Markers.

Authors:  Ethan Schroeder; Li Yuan; Eunju Seong; Cheryl Ligon; Nicholas DeKorver; C B Gurumurthy; Jyothi Arikkath
Journal:  Mol Neurobiol       Date:  2018-10-04       Impact factor: 5.590

5.  Heterozygous CDKL5 Knockout Female Mice Are a Valuable Animal Model for CDKL5 Disorder.

Authors:  Claudia Fuchs; Laura Gennaccaro; Stefania Trazzi; Stefano Bastianini; Simone Bettini; Viviana Lo Martire; Elisa Ren; Giorgio Medici; Giovanna Zoccoli; Roberto Rimondini; Elisabetta Ciani
Journal:  Neural Plast       Date:  2018-05-27       Impact factor: 3.599

Review 6.  Cyclin-Dependent Kinase-Like 5 (CDKL5): Possible Cellular Signalling Targets and Involvement in CDKL5 Deficiency Disorder.

Authors:  Syouichi Katayama; Noriyuki Sueyoshi; Tetsuya Inazu; Isamu Kameshita
Journal:  Neural Plast       Date:  2020-06-05       Impact factor: 3.599

Review 7.  Rett Syndrome and CDKL5 Deficiency Disorder: From Bench to Clinic.

Authors:  Shilpa D Kadam; Brennan J Sullivan; Archita Goyal; Mary E Blue; Constance Smith-Hicks
Journal:  Int J Mol Sci       Date:  2019-10-15       Impact factor: 5.923

Review 8.  Sleep Disorders in Rett Syndrome and Rett-Related Disorders: A Narrative Review.

Authors:  Giorgia Tascini; Giovanni Battista Dell'Isola; Elisabetta Mencaroni; Giuseppe Di Cara; Pasquale Striano; Alberto Verrotti
Journal:  Front Neurol       Date:  2022-03-01       Impact factor: 4.003

9.  Age-Related Cognitive and Motor Decline in a Mouse Model of CDKL5 Deficiency Disorder is Associated with Increased Neuronal Senescence and Death.

Authors:  Laura Gennaccaro; Claudia Fuchs; Manuela Loi; Riccardo Pizzo; Sara Alvente; Chiara Berteotti; Leonardo Lupori; Giulia Sagona; Giuseppe Galvani; Antonia Gurgone; Alessandra Raspanti; Giorgio Medici; Marianna Tassinari; Stefania Trazzi; Elisa Ren; Roberto Rimondini; Tommaso Pizzorusso; Giovanna Zoccoli; Maurizio Giustetto; Elisabetta Ciani
Journal:  Aging Dis       Date:  2021-06-01       Impact factor: 6.745

10.  Inhibition of microglia overactivation restores neuronal survival in a mouse model of CDKL5 deficiency disorder.

Authors:  Giuseppe Galvani; Nicola Mottolese; Laura Gennaccaro; Manuela Loi; Giorgio Medici; Marianna Tassinari; Claudia Fuchs; Elisabetta Ciani; Stefania Trazzi
Journal:  J Neuroinflammation       Date:  2021-07-08       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.